---
title: 
layout: article
permalink: 
---

#### Selected Publications 

 <span style="color:#B8860B">2017</span>

Kim JB\*, Pjanic M\*, Nguyen T, Miller CL, Iyer D, Liu B, Wang T, Sazonova O, Carcamo-Orive I, Matic LP, Maegdefessel L, Hedin U, Quertermous T.[TCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cells.][26] PLOS Genetics. 2017 May 8;13(5):e1006750.

<span style="color:#B8860B">2016</span>

Miller CL† and Leeper NJ. [GWAS candidate gene to dual modifier of non-alcoholic fatty liver disease and atherosclerosis.][1] Journal of the American College of Cardiology: Basic to Translational Science. 2016.   

Pjanic M, Miller CL, Wirka R, Kim BK, DiRenzo D, Quertermous T. [Genetics and genomics of coronary artery disease.][3] Current Cardiology Reports. 2016. Oct;18(10):102.

Perisic L, Rykaczewska U, Razuvaev A, Sabater-Lleal M, Lengquist M, Miller CL, Eriksson I, Röhl S, Aldi S, Kronqvist M, Gonzalez Diez M, Roy J, Baldassarre D, Veglia F, Humphries SE, de Faire, U, Tremoli E, IMPROVE study group, Odeberg J, Vukojevic V, Paulsson-Berne G, Hansson GK, Lindeman JHN, Eriksson P, Quertermous T, Hamsten A, Hedin U. [Phenotypic modulation of smooth muscle cells in atherosclerosis is associated with downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM.][4] Arteriosclerosis, Thrombosis and Vascular Biology. 2016 Sep;36(9):1947-61. 

Kojima Y‡, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, DiRenzo D, Nanda V, Brady S, Connelly AP, Schadt EE, Quertermous T, Betancur PA, Maegdefessel L, Perisic L, Hedin U, Weissman I, Leeper NJ. [CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis.][5] Nature. 2016 Aug 4;536(7614):86-90. 

Miller CL\*†, Pjanic M\*, Wang T, Nguyen T, Cohain A, Lee JD, Perisic L, Hedin U, Kundu RK, Majmudar D, Kim JB, Wang O, Betsholtz C, Ruusalepp A, Franzen O, Assimes TL, Montgomery SB, Schadt EE, Björkegren J, Quertermous T. [Integrative functional genomics identifies regulatory mechanisms at coronary heart disease loci.][6] Nature Communications. 2016 Jul 8;7:12092. 

<span style="color:#B8860B">2015</span>

Miller CL\*, Pjanic M\*, Quertermous T. [From locus association to mechanism of gene causality: the devil is in the details.][9] Arteriosclerosis, Thrombosis and Vascular Biology. 2015 Oct;35(10):2079-80.

Nürnberg ST\*, Cheng K\*, Raiesdana A, Kundu RK, Miller CL, Arora K, Carcamo-Oribe I, Xiong Y, Kim JB, Tellakula N, Murthy N, Bolsvert WA, Owens GK, Tallquist MD, Quertermous T. [TCF21 regulates smooth muscle cell precursor cells that contribute to the fibrous cap.][10] PLOS Genetics. 2015 May 28;11(5):e1005155.

Sazonova OV\*, Zhao Y\*, Nürnberg ST\*, Miller CL, Pjanic M, Kundaje AB, Bejerano G, Assimes TL, Yang X, Quertermous T. [Characterization of TCF21 downstream target regions identifies a transcriptional pathway linking multiple independent coronary heart disease loci.][11] PLOS Genetics. 2015 May 28;11(5):e1005202. 

<span style="color:#B8860B">2014</span>

Miller CL†, Haas U, Diaz R, Leeper NJ, Kundu RK, Patolla B, Assimes TL, Kaiser FJ, Ljubica P, Hedin U, Maegdefessel L, Schunkert H, Erdmann J, Quertermous T†, Sczakiel G†. [Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation.][12] PLOS Genetics. 2014 Mar 27; 10(3):e1004263.

Miller CL, Assimes TL, Montgomery SB, Quertermous T. [Dissecting the causal genetic mechanisms of coronary heart disease.][13] Current Atherosclerosis Reports. 2014 May;16(5):406.

Kojima Y, Downing KP, Kundu RK, Miller CL, Dewey F, Lancero H, Raaz U, Perisic L, Hedin U, Schadt EE, Maegdefessel L, Quertermous T, Leeper NJ. [CDKN2B regulates efferocytosis and atherosclerosis.][14] Journal of Clinical Investigation. 2014 Mar 3;124(3):1083-97. 

<span style="color:#B8860B">2013</span>

Miller CL†, Anderson DR, Kundu RK, Raiesdana A, Nürnberg ST, Diaz R, Cheng K, Leeper NJ, Chen CH, Chang IS, Schadt EE, Hsiung CA, Assimes TL, Quertermous T†. [Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus.][15] PLOS Genetics. 2013 Jul;9(7):e1003652.

Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, Miller CL, Roberts SC, Spin JM, de Almeida PE, Wu JC, Xu B, Cheng K, Quertermous M, Kundu S, Kortekaas KE, Berzin E, Downing KP, Dalman RL, Tsao PS, Schadt EE, Owens GK, Quertermous T. [Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.][16] Arteriosclerosis, Thrombosis and Vascular Biology. 2013 Jan;33(1):e1-e10. 

<span style="color:#B8860B">2011</span>

Miller CL, Oikawa M, Cai Y, Thomas T, Dostmann W, Zaccolo M, Fujiwara K, Yan C. [Cyclic nucleotide phosphodiesterase 1: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.][17] Basic Research in Cardiology. 2011 Nov;106(6): 1023-39.  

<span style="color:#B8860B">2010 and prior</span>

Cai Y, Miller CL, Nagel DJ, Jeon KI, Lim S, Gao P, Knight PA, Yan C. [Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells.][18] Arteriosclerosis, Thrombosis and Vascular Biology. 2010 Dec 9;31(3): 616-23. 

Miller CL, Yan C. [Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.][20] Journal of Cardiovascular Translational Research. 2010 Oct;3(5): 507-15. 

Miller CL‡, Oikawa M, Cai Y, Wojtovich AP, Nagel DJ, Xu X, Xu, H, Rybalkin SD, Beavo JA, Chen YF, Li JD, Blaxall BC, Abe J, Yan C. [Role of Ca2+/CaM-stimulated phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.][21] Circulation Research. 2009 Nov 6;105(10): 956-64.  

Yan C, Miller CL, Abe J. [Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.][22] Circulation Research. 2007 Mar 2;100(4): 489-501.

\* authors contributed equally.
† corresponding author.
‡ manuscript received editorial.

See complete list of publications on [Pubmed][27] or [Google Scholar][28].

[1]: http://www.basictranslational.onlinejacc.org/content/1/7/680
[3]: http://link.springer.com/article/10.1007%2Fs11886-016-0777-y
[4]: http://atvb.ahajournals.org/content/early/2016/07/28/ATVBAHA.116.307893
[5]: http://www.nature.com/nature/journal/v536/n7614/full/nature18935.html
[6]: http://www.nature.com/articles/ncomms12092
[9]: http://atvb.ahajournals.org/content/35/10/2079.long
[10]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005155
[11]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005202
[12]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004263
[13]: http://link.springer.com/article/10.1007%2Fs11883-014-0406-4
[14]: https://www.jci.org/articles/view/70391
[15]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1003652
[16]: http://atvb.ahajournals.org/content/33/1/e1.long
[17]: http://link.springer.com/article/10.1007%2Fs00395-011-0228-2
[18]: http://atvb.ahajournals.org/content/31/3/616.long
[20]: http://link.springer.com/article/10.1007%2Fs12265-010-9203-9
[21]: http://circres.ahajournals.org/content/105/10/956.long
[22]: http://circres.ahajournals.org/content/100/4/489.long
[26]: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1006750
[27]: https://www.ncbi.nlm.nih.gov/pubmed/?term=Clint+Miller+NOT+Miller+CT
[28]: https://scholar.google.com/citations?user=hkc4nPAAAAAJ&hl=en
